Correspondence 0001493152-22-034003 from Scienture Holdings, Inc. (SCNX)
Scienture Holdings, Inc.
Date: Nov. 30, 2022 · CIK: 0001382574 · Accession: 0001493152-22-034003
AI Filing Summary & Sentiment
File numbers found in text: 333-268574
Show Raw Text
CORRESP
1
filename1.htm
November
30, 2022
VIA
EDGAR
Division
of Corporate Finance
U.S.
Securities and Exchange Commission
Office
of Trade & Services
100
F Street, N.E.
Washington
D.C. 20549
Re: TRxADE
HEALTH, INC.
Form
S-1 Registration Statement
Filed
November 28, 2022
File
No. 333-268574
Acceleration
Request
Request
Date: Friday, December 2, 2022
Request
Time: 4:00 p.m. Eastern Time (or as soon thereafter as practicable)
Ladies
and Gentlemen:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended, TRxADE HEALTH, INC. (the “Registrant”) hereby requests that
the United States Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-captioned
Registration Statement (the “Registration Statement”) to become effective on Friday, December 2, 2022, at 4:00 p.m.,
Eastern Time, or as soon thereafter as practicable.
The
Registrant hereby authorizes David M. Loev and/or John S. Gillies of The Loev Law Firm, PC, to orally modify or withdraw this request
for acceleration. Please contact Mr. Loev at (832) 930-6432, with any questions you may have concerning this request, and please notify
him when this request for acceleration has been granted.
Sincerely,
/s/
Suren Ajjarapu
Suren
Ajjarapu
Chief
Executive Officer